Tags |
|
|
Links |
|
|
Write You - Global Economic Power Shifts From The U.S. And Europe To Asia
India just reported GDP growth of 9.4% for the fiscal year ended March 2007. This is way above the 8% predicted rate of growth and moving toward China’s stunning 10.4% growth rate.
I
I
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ndia, like China is becoming an engine of global growth. The U.S. is clearly no longer the important engine of global growth that it once was. Let us face facts. The U.S. has lost muc
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
h of its global political leadership, and now its global economic leadership is coming into question.
The U.S. is still the world’s biggest economy, but with a growth rate of less th
The U.S. is still the world’s biggest economy, but with a growth rate of less th
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
an 1% in the last quarter, and with close to double digit growth in India and China there is little doubt that the U.S. will lose its status as the world’s biggest economy within a de
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
cade if these trends persist.
We are American, and we are pro-America, but we are also realists. Let us invest in those areas where the money is to be made. Let us invest in the coun
We are American, and we are pro-America, but we are also realists. Let us invest in those areas where the money is to be made. Let us invest in the coun
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tries that are growing fast and in the commodities and precious metals which will benefit from these trends. Let us look at the transportation companies whose products and services ar
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
e necessary to effectuate this growth and at the energy and base metals which are the building blocks of any economy. Let us also look at the global financial intermediaries that will
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
provide the financing for this growth and at the precious metals stocks where many of the profits will be invested.
In our opinion, gold will play a major part as a vehicle that cen
In our opinion, gold will play a major part as a vehicle that cen
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
tral banks will acquire to strengthen their balance sheets. Recently, Spain sold some gold. The buyers were the central banks of countries with growing economies-the buyers were Asian
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
central banks.
As power shifts from the U.S. and Europe to Asia, so do the central bank gold holdings shift from U.S. and Europe to Asia.
For more information on global investment
As power shifts from the U.S. and Europe to Asia, so do the central bank gold holdings shift from U.S. and Europe to Asia.
For more information on global investment
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
isit http://www.howtoinvestglobally.com For more information on Monty Guild's investment management visit http://www.guildinvestment.com
These articles are for informational purposes
These articles are for informational purposes
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
only and are not intended to be a solicitation, offering or recommendation of any security. Guild Investment Management does not represent that the securities, products, or services
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
discussed in this web site are suitable or appropriate for all investors. Any market analysis constitutes an opinion that may not be correct. Readers must make their own independent i
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
nvestment decisions. The information in this article is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
would be contrary to law or regulation, or which would subject Guild Investment Management to any registration requirement within such jurisdiction or country.
Any opinions expresse
Any opinions expresse
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
d herein, are subject to change without notice. In addition, there are many market, currency, economic, political, business, technological and other risks that are beyond our control.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
We make reasonable efforts to provide accurate content in these articles; however, some content and some of the assumptions, formulas, algorithms and other data that impact the conte
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
nt may be inaccurate, outdated, or otherwise inappropriate. In addition, we may have conflicts of interest with respect to any investments mentioned. Our principals and our clients ma
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
y hold positions in investments mentioned on the site or we may take positions contrary to investments mentioned.
Guild’s current and past market commentaries are protected by copyri
Guild’s current and past market commentaries are protected by copyri
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ght. Apart from any use permitted under the Copyright Act, you must not copy, frame, modify, transmit or distribute the market commentaries, without seeking the prior consent of Guild
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.writeyou.org.ua/article/101506/writeyou-Global-Economic-Power-Shifts-From-The-US-And-Europe-To-Asia.html">Global Economic Power Shifts From The U.S. And Europe To Asia</a>
BB link (for phorums):
[url=http://www.writeyou.org.ua/article/101506/writeyou-Global-Economic-Power-Shifts-From-The-US-And-Europe-To-Asia.html]Global Economic Power Shifts From The U.S. And Europe To Asia[/url]
Related Articles:
MSN PPC Advertising Network Finally Debuts
Easy And Simple Steps To Get Listed In Search Engines
Bookmark it:
|